DGX

Quest Diagnostics (DGX)

Quest Diagnostics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:DGX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	05 : 08	PR Newswire (US)	Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum	NYSE:DGX	Quest Diagnostics Inc
2024/05/22	05 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	22 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/21	08 : 11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/05/17	05 : 15	PR Newswire (US)	Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors	NYSE:DGX	Quest Diagnostics Inc
2024/05/16	06 : 45	PR Newswire (US)	Quest Diagnostics Declares Quarterly Cash Dividend	NYSE:DGX	Quest Diagnostics Inc
2024/05/15	21 : 43	PR Newswire (US)	Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests	NYSE:DGX	Quest Diagnostics Inc
2024/05/08	05 : 50	PR Newswire (US)	Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference	NYSE:DGX	Quest Diagnostics Inc
2024/05/06	22 : 40	PR Newswire (US)	Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer	NYSE:DGX	Quest Diagnostics Inc
2024/05/01	19 : 57	PR Newswire (US)	Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI	NYSE:DGX	Quest Diagnostics Inc
2024/04/23	19 : 45	PR Newswire (US)	Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024	NYSE:DGX	Quest Diagnostics Inc
2024/04/22	20 : 53	PR Newswire (US)	Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	NYSE:DGX	Quest Diagnostics Inc
2024/04/02	20 : 57	PR Newswire (US)	Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay	NYSE:DGX	Quest Diagnostics Inc
2024/03/26	20 : 09	PR Newswire (US)	Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease	NYSE:DGX	Quest Diagnostics Inc
2024/03/20	04 : 06	PR Newswire (US)	Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc
2024/03/02	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:DGX	Quest Diagnostics Inc